StockData
HUMNYSEHospital & Medical Service PlansFiscal year ends December 31

HUMANA INC

Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Jul 29, 2026
$414.98+1.82 (+0.44%)

Close on Oct 19, 2026

Market cap
$50.07B
P/E (TTM)
44.2
Dividend yield
0.85%

About Humana

Hospital & Medical Service Plans, SIC 6324

Humana Inc. provides health insurance and healthcare delivery services across two primary operating divisions: Insurance and CenterWell. The Insurance segment offers Medicare Advantage, Medicare Supplement, stand-alone prescription drug plans, and Medicaid coverage, alongside specialty benefits such as dental, vision, life, and disability plans. It also delivers pharmacy benefit management and administrative services for military healthcare programs. CenterWell operates physician-directed clinical capabilities, including senior-focused primary care clinics, pharmacy solutions spanning mail-order and specialty fulfillment, and in-home health services. The company serves Medicare and Medicaid beneficiaries, individual policyholders, employer groups, and military personnel and their families.

The organization maintains a nationwide footprint, offering Medicare plans across all fifty states. Its CenterWell division operates 350 senior primary care clinics across fifteen states, employing roughly 1,300 care providers, while its home health operations extend to 37 states. Humana maintains its principal executive headquarters in Louisville, Kentucky.

Summary of the business section of Humana's latest annual report, written by StockData.

Company profile

Company

Legal name
HUMANA INC
Founded
1964
Headquarters
Louisville, KY
Address
101 E. Main Street
Phone
(502) 580-1000
Website
humana.com
Employees
67,060, Dec 31, 2025
Industry
Hospital & Medical Service Plans
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
PricewaterhouseCoopers LLP, Louisville, Kentucky

Stock & identifiers

Ticker
HUM
Exchange
NYSE
Shares outstanding
120M, Jun 30, 2026
Public float
$29.18B, Jun 30, 2025
Filer category
Large accelerated filer
Stock splits
3-for-2, Aug 1, 1991; 6-for-5, Feb 1, 1984; 4-for-3, Feb 1, 1983; 3-for-2, Feb 1, 1982
SEC CIK
49071
CUSIP
444859102
ISIN
US4448591028
LEI
529900YLDW34GJAO4J06
EIN
61-0647538

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Shantanu NundyChief Medical Officer2,549
Joseph C. VenturaChief Legal Officer27,699
Sanjay K. ShettyPresident, CenterWell22,088
David DintenfassPresident, Enterprise Growth25,407
Michelle A. O'HaraChief Human Resources Officer20,026
James A. RechtinPresident & CEO67,631
Celeste MelletChief Financial Officer39,637
Aaron MartinPresident, Medicare Advantage25,237
Japan MehtaChief Information Officer17,176
George Renaudin IIPresident, Insurance16,617
John-Paul W. FelterSVP, Chief Accting Off & Cont.7,484
Vishal AgrawalChief Strat & Corp Dev Officer16,717
Susan M. DiamondChief Financial Officer22,384
Timothy S. HuvalChief Administrative Officer7,111
Samir DeshpandeChief Information Officer13,639
Frederick John CrawfordDirector565
Paul John SmithDirector544
Kurt J. HilzingerDirector19,448
Robert Stuart FieldDirector852
Karen KatzDirector590
Raquel C. BonoDirector397
John W. GarrattDirector1,685
Jorge S. MesquitaDirector4,975
David T. FeinbergDirector1,207
Marcy S. KlevornDirector436

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
Mr Rechtin
$18.76M$18.83M$9.39M$65$108
FY2024
Mr Broussard
$12.06M$184.36K$10.07M$64$107
FY2024
Mr Rechtin
$15.58M$9.23M$10.07M$64$107
FY2023
Mr Broussard
$16.33M-$37.71K$3.87M$114$115
FY2023
Mr. Broussard
$16.33M-$37.71K$3.87M$114$115
FY2022
Mr Broussard
$17.20M$30.35M$4.15M$126$116

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we had approximately 67,060 associates.”

Corporate history

Events identified from SEC filings

DateEventDetails
Aug 14, 2018Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Aug 28, 2015Merger voteDefinitive merger proxy statement